NC
ABBV icon

NBW Capital’s AbbVie ABBV Stock Holding History

NBW Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$5.68M Buy
30,614
+268
+0.9% +$49.8K 1.23% 31
2025
Q1 		$6.36M Sell
30,346
-8,569
-22% -$1.67M 1.41% 25
2024
Q4 		$6.92M Sell
38,915
-603
-2% -$111K 1.28% 31
2024
Q3 		$7.8M Buy
39,518
+836
+2% +$156K 1.47% 27
2024
Q2 		$6.63M Buy
38,682
+35,631
+1,168% +$5.9M 1.31% 32
2024
Q1 		$556K Buy
3,051
+13
+0.4% +$2.24K 0.11% 73
2023
Q4 		$471K Sell
3,038
-246
-7% -$35.9K 0.1% 71
2023
Q3 		$490K Buy
3,284
+152
+5% +$22.3K 0.12% 72
2023
Q2 		$422K Buy
3,132
+179
+6% +$26.2K 0.1% 77
2023
Q1 		$471K Buy
2,953
+1
+0% +$153 0.11% 76
2022
Q4 		$477K Buy
2,952
+242
+9% +$37.1K 0.12% 75
2022
Q3 		$364K Buy
+2,710
New +$389K 0.1% 78
2022
Q2 		– Sell
-1,305
Closed -$212K – 84
2022
Q1 		$212K Sell
1,305
-232
-15% -$33.7K 0.05% 81
2021
Q4 		$208K Buy
+1,537
New +$182K 0.05% 83

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

NBW Capital's ABBV Position: Q2 2025 in Review

NBW Capital increased its AbbVie (ABBV) stake by 0.88% in Q2 2025, buying an estimated $49.8K and bringing the position to 30,614 shares worth $5.68M. The position accounts for 1.23% of the portfolio, ranked #31.

NBW Capital first reported a position in ABBV in Q4 2021 and has held it in 14 quarters since. The position peaked at $7.8M in Q3 2024. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • NBW Capital held 30,614 shares of AbbVie worth $5.68M as of Q2 2025.
  • NBW Capital bought 268 AbbVie shares in Q2 2025, an estimated $49.8K.
  • AbbVie made up 1.23% of NBW Capital's portfolio in Q2 2025, its #31 holding.
  • NBW Capital first reported a position in AbbVie in Q4 2021 and has held it in 14 quarters since.
  • NBW Capital's AbbVie position peaked at $7.8M in Q3 2024.
  • 3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on NBW Capital's 13F filing for Q2 2025, filed 13 Aug 2025.